News und Analysen
McDonald’s stock serves up a buy-the-dip opportunity
McDonald’s (NYSE: MCD) had a solid quarter, but headwinds cut into the top line and will persist for the foreseeable future. The headwinds include war in the Middle East and consumer pull-back in
McDonald’s stock serves up a buy-the-dip opportunity
McDonald’s (NYSE: MCD) had a solid quarter, but headwinds cut into the top line and will persist for the foreseeable future. The headwinds include war in the Middle East and consumer pull-back in
Corbus Pharmaceuticals stock: An explosive 342% YTD surge
Shares of Corbus Pharmaceuticals (NASDAQ: CRBP) have already experienced a meteoric rise of over 300% year-to-date. This is thanks to fresh news released two Fridays ago, on January 26. The
Verizon, Walgreens, 3M: 3 high-yield Dow stocks to buy now?
Verizon Communications Inc. (NYSE: VZ), Walgreens Boots Alliance Inc. (NASDAQ: WBA) and 3M (NYSE: MMM) are among the highest-yielding components of the Dow Jones Industrial Average.
Are these
Verizon, Walgreens, 3M: 3 high-yield Dow stocks to buy now?
Verizon Communications Inc. (NYSE: VZ), Walgreens Boots Alliance Inc. (NASDAQ: WBA) and 3M (NYSE: MMM) are among the highest-yielding components of the Dow Jones Industrial Average.
Are these
Clorox cleans up after post-COVID normalization and a cyberattack
The Clorox Co. (NYSE: CLX) is a household name, especially after the pandemic. The name is synonymous with disinfectants and cleaning products. Clorox is a member of the consumer staples sector
2 solar tracker stocks to make your portfolio sizzle in 2024
Solar energy stocks have had a rollercoaster ride in the past few years. From solar panels to microinverters, there is no part of a solar energy system that can't experience supply and demand
Goodyear Tires can benefit from EVs, but not how you may think
The Goodyear Tire and Rubber Company (NASDAQ: GT) shareholders have breathed a sigh of relief with the events of the past few months, which include a new CEO who has the backing of activist
PayPal stock making a sudden turn, earnings breakout?
The market is currently at a tipping point, whether investors at large want to admit it or not. With the major indices trading at all-time highs, most market participants tend to fall into a
PayPal stock making a sudden turn, earnings breakout?
The market is currently at a tipping point, whether investors at large want to admit it or not. With the major indices trading at all-time highs, most market participants tend to fall into a
PayPal stock making a sudden turn, earnings breakout?
The market is currently at a tipping point, whether investors at large want to admit it or not. With the major indices trading at all-time highs, most market participants tend to fall into a
3 cheap utility stocks that shouldn't be so
Everyone is worrying about the rising effects of the Red Sea conflict. Most investors will likely see success in following the pop in oil prices through stocks like Hess (NYSE: HES) for reasons
Tyson stock could see a boost in profits as costs normalize
The markets have been on a wild tear so far into the new year, with indices like the S&P 500 and NASDAQ hitting fresh all-time highs. However, not all sectors – and stocks – are created equal in
Eilt: Hautkrebs vollständig geheilt - Institutionelle Investoren begeistert. Neuer 312% Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). Jetzt 312% mit Biotech Aktientip
Eilt: Hautkrebs vollständig geheilt - Institutionelle Investoren begeistert. 312% Biotech Aktientip nach 15973% BioNTech
05.02.24 08:02
London (www.aktiencheck.de , Anzeige)
Eilt: Hautkrebs vollständig geheilt - Institutionelle Investoren begeistert. Neuer 312% Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). Jetzt 312% mit Biotech Aktientip
Eilt: Hautkrebs vollständig geheilt - Institutionelle Investoren begeistert. 312% Biotech Aktientip nach 15973% BioNTech
05.02.24 08:02
London (www.aktiencheck.de , Anzeige)
Eilt: Hautkrebs vollständig geheilt - Institutionelle Investoren begeistert. Neuer 312% Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). Jetzt 312% mit Biotech Aktientip
Eilt: Hautkrebs vollständig geheilt - Institutionelle Investoren begeistert. 312% Biotech Aktientip nach 15973% BioNTech
05.02.24 08:02
London (www.aktiencheck.de , Anzeige)
1 Billionen $ Marktchance Mentale Gesundheit - 6 Mio. $ Finanzierung. KUV von nur 1. Wettbewerber 26 mal höher bewertet. Mental Health Hot Stock mit 260% Umsatzwachstum. Jetzt 233% mit Mentale Gesundheits Aktientip 2024 Numinus Wellness
1 Billionen $ Marktchance Mentale Gesundheit - 6 Mio. $ Finanzierung. Mental Health Hot Stock mit 260% Umsatzwachstum
05.02.24 08:18
Vancouver (www.aktiencheck.de , Anzeige)
AbbVie turns a corner; patent cliff fears were overblown
AbbVie (NYSE: ABBV) is turning an important corner in 2024 and is on track to resume growth. Its Humira-related patent cliff aside, the business is stronger than ever, and the patent cliff is more
Amazon stock on the verge of a 40% rally
A 7% jump in Friday's pre-market session should tell you everything you need about Amazon.com Inc. (NASDAQ: AMZN) Q4 results. The e-commerce giant released them after the bell rang to end
Amazon stock on the verge of a 40% rally
A 7% jump in Friday's pre-market session should tell you everything you need about Amazon.com Inc. (NASDAQ: AMZN) Q4 results. The e-commerce giant released them after the bell rang to end
Amazon stock on the verge of a 40% rally
A 7% jump in Friday's pre-market session should tell you everything you need about Amazon.com Inc. (NASDAQ: AMZN) Q4 results. The e-commerce giant released them after the bell rang to end
Coca-Cola: Top-Rated dividend stock breaks out ahead of earnings
Shares of Coca-Cola (NYSE: KO), the Top-Rated Dividend stock, household brand name, and consumer staple giant, have staged a notable turnaround and comeback lately, with its stock rising close to
Magnificent Meta Platforms stock will double in value
Meta Platforms (NASDAQ: META) still has a long way to go to double its valuation from the pre-Q4 release market cap, but it is on track to hit a $2 trillion valuation. The company’s leaning into
Magnificent Meta Platforms stock will double in value
Meta Platforms (NASDAQ: META) still has a long way to go to double its valuation from the pre-Q4 release market cap, but it is on track to hit a $2 trillion valuation. The company’s leaning into
Magnificent Meta Platforms stock will double in value
Meta Platforms (NASDAQ: META) still has a long way to go to double its valuation from the pre-Q4 release market cap, but it is on track to hit a $2 trillion valuation. The company’s leaning into